title: The extended latissimus dorsi flap option in autologous breast reconstruction: A report of 14 cases and review of the literature.
abstract: BACKGROUND
  Autologous breast reconstruction using the extended latissimus dorsi flap has been infrequently reported. In the current study, the authors are reporting their own clinical experience with this method. A review of the literature is also discussed.
  
  
  METHODS
  Over a three year period, 14 patients underwent breast reconstruction using the extended latissimus dorsi (LD) flap. Patients with small to medium sized breasts were selected. The age of the patients ranged from 29 to 42 years with a follow-up period ranging from six to 18 months. The indications, flap-related complications and donor site morbidity and aesthetic results were evaluated.
  
  
  RESULTS
  The main indication to use the flap was dorsal donor site preference by patients. The remaining patients were either not suitable for a flap from the abdomen or wished to get pregnant and were offered the dorsal donor site. Neither total nor partial flap loss was recorded but donor site morbidity was mainly due to seroma, which was treated conservatively in all patients, except for one who required surgery. Another two patients suffered from wound breakdown and distal necrosis of the back flaps. Mild contour deformity was also noted on the back of all patients but caused no major concern. Indeed, the overall patient satisfaction was very high.
  
  
  CONCLUSIONS
  The extended LD flap proved to be a good option for autologous breast reconstruction in selected patients. Patients should be warned of the potential for seroma and mild contour back deformity.
authors.forename: Mohammed A
authors.initials: MA
authors.lastname: Rifaat
authors.forename: Ayman A
authors.initials: AA
authors.lastname: Amin
authors.forename: Mahmoud
authors.initials: M
authors.lastname: Bassiouny
authors.forename: Ayman
authors.initials: A
authors.lastname: Nabawi
authors.forename: Sherif
authors.initials: S
authors.lastname: Monib